Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells

Vaccine

Volumn 24, Issue 15, 2006, Pages 2966-2974

  Yang, Xiuli ^a,b   Chu, Yiwei ^a,b   Wang, Ying ^a,b   Guo, Qiang ^a,b   Xiong, Sidong ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Shanghai Institute of Immunology   (China)

Author keywords

4T1; Anti tumor immunity; ITAC

Indexed keywords

4T1 ITAC VACCINE; ALPHA INTERFERON; CHEMOATTRACTANT; DNA; GAMMA INTERFERON; INTERFERON INDUCIBLE T CELL ALPHA CHEMOATTRACTANT; INTERLEUKIN 4; TUMOR CELL VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATTENUATION; BREAST CARCINOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CELLULAR IMMUNITY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; GENETIC ANALYSIS; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOTHERAPY; INCIDENCE; INHIBITION KINETICS; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; TH1 CELL; TUMOR IMMUNITY; VACCINATION;

ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; CHEMOKINES, CXC; COLON; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HISTOCYTOCHEMISTRY; LUNG; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 33644930821     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.12.004     Document Type: Article

References (31)

1. H. Huang, Y. Liu, and J. Xiang Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors Cell Immunol 217 2002 12
2. T. Nanki, and P.E. Lipsky Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation J Immunol 164 2000 5010
3. D. D'Ambrosio, C. Albanesi, R. Lang, G. Girolomoni, F. Sinigaglia, and C. Laudanna Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion J Immunol 169 2002 2303
4. I. Clark-Lewis, I. Mattioli, J.H. Gong, and P. Loetscher Structure-function relationship between the human chemokine receptor CXCR3 and its ligands J Biol Chem 278 2003 289
5. A. Ludwig, F. Schiemann, R. Mentlein, B. Lindner, and E. Brandt Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine J Leukoc Biol 72 2002 183
6. R.A. Colvin, G.S. Campanella, J. Sun, and A.D. Luster Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function J Biol Chem 279 2004 30219
7. M. Meyer, P.J. Hensbergen, E.M. van der Raaij-Helmer, G. Brandacher, R. Margreiter, and C. Heufler Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection Eur J Immunol 31 2001 2521
8. A. Sauty, R.A. Colvin, L. Wagner, S. Rochat, F. Spertini, and A.D. Luster CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11) J Immunol 167 2001 7084 7093
9. D.P. Widney, Y.R. Xia, A.J. Lusis, and J.B. Smith The murine chemokine CXCL11 (IFN-inducible T cell alpha chemoattractant) is an IFN-gamma- and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia J Immunol 164 2000 6322
10. G. Xanthou, C.E. Duchesnes, T.J. Williams, and J.E. Pease CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 Eur J Immunol 33 2003 2241
11. S.R. McColl, S. Mahalingam, M. Staykova, L.A. Tylaska, K.E. Fisher, and C.A. Strick Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands Lab Invest 84 2004 1418
12. J. Flier, D.M. Boorsma, P.J. van Beek, C. Nieboer, T.J. Stoof, and R. Willemze Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation J Pathol 194 2001 398
13. J. Kao, J. Kobashigawa, M.C. Fishbein, W.R. MacLellan, M.D. Burdick, and J.A. Belperio Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease Circulation 107 2003 1958
14. B.A. Pulaski, D.S. Terman, S. Khan, E. Muller, and S. Ostrand-Rosenberg Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model Cancer Res 60 2000 2710
15. B.A. Pulaski, and S. Ostrand-Rosenberg Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines Cancer Res 58 1998 1486
16. R. Martinelli, I. Sabroe, G. LaRosa, T.J. Williams, and J.E. Pease The CC chemokine eotaxin (CCL11) is a partial agonist of the chemokine receptor CCR2b J Biol Chem 276 2001 42957
17. H. Lecoeur, M. Fevrier, S. Garcia, Y. Riviere, and M.L. Gougeon A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity J Immunol Methods 253 2001 177
18. P. Yu, M.T. Spiotto, Y. Lee, H. Schreiber, and Y.X. Fu Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells J Exp Med 197 2003 985
19. U. Pertl, A.D. Luster, N.M. Varki, D. Homann, G. Gaedicke, and R.A. Reisfeld IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy J Immunol 166 2001 6944
20. M. Mitsuhashi, J. Liu, S. Cao, X. Shi, and X. Ma Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas J Leukoc Biol 76 2004 322
21. S. Demaria, N. Kawashima, A.M. Yang, M.L. Devitt, J.S. Babb, and J.P. Allison Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer Clin Cancer Res 11 2005 728
22. T. Steinberg, P. Ohlschl, P. Sehr, W. Osen, and L. Gissmann Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice Vaccine 23 2005 1149
23. H.N. Lode, T. Dreier, R. Xiang, N.M. Varki, A.S. Kang, and R.A. Reisfeld Gene therapy with a single chain interlukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma Proc Natl Acad Sci USA 95 1998 2475
24. S.K. Dissanayake, J.A. Thompson, J.J. Bosch, V.K. Clements, P.W. Chen, and B.R. Ksander Activation of tumor-specific CD4+ T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy Cancer Res 64 2004 1867
25. J.H. Dufour, M. Dziejman, M.T. Liu, J.H. Leung, T.E. Lane, and A.D. Luster IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking J Immunol 168 2002 3195
26. D. Whiting, G. Hsieh, J.J. Yun, A. Banerji, W. Yao, and M.C. Fishbein Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production J Immunol 172 2004 7417
27. K. Ogasawara, S. Hida, Y. Weng, A. Saiura, K. Sato, and H. Takayanagi Requirement of the IFN-alpha/beta-induced CXCR3 chemokine signalling for CD8+ T cell activation Genes Cells 7 2002 309
28. I.M. Mullins, C.L. Slingluff, J.K. Lee, C.F. Garbee, J.F. Shu, and S.G. Anderson CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease Cancer Res 64 2004 7697
29. R. Bonecchi, G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, and A. Borsatti Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 187 1998 129
30. W. Zou, J. Borvak, F. Marches, S. Wei, P. Galanaud, and D. Emilie Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12 J Immunol 165 2000 4388
31. J.H. Xie, N. Nomura, M. Lu, S.L. Chen, G.E. Koch, and Y. Weng Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation J Leukoc Biol 73 2003 771